NBW Capital LLC Sells 2,012 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

NBW Capital LLC cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 22.8% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 6,798 shares of the healthcare conglomerate's stock after selling 2,012 shares during the period. NBW Capital LLC's holdings in UnitedHealth Group were worth $3,560,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in the business. Financial Management Professionals Inc. increased its stake in UnitedHealth Group by 0.8% during the first quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate's stock valued at $1,165,000 after acquiring an additional 17 shares during the period. Global Wealth Strategies & Associates increased its stake in UnitedHealth Group by 28.6% during the first quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate's stock valued at $47,000 after acquiring an additional 20 shares during the period. Kolinsky Wealth Management LLC increased its stake in UnitedHealth Group by 1.0% during the fourth quarter. Kolinsky Wealth Management LLC now owns 2,135 shares of the healthcare conglomerate's stock valued at $1,080,000 after acquiring an additional 21 shares during the period. Retirement Planning Group LLC increased its stake in UnitedHealth Group by 5.1% during the first quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate's stock valued at $225,000 after acquiring an additional 21 shares during the period. Finally, Net Worth Advisory Group increased its stake in UnitedHealth Group by 0.6% during the first quarter. Net Worth Advisory Group now owns 3,642 shares of the healthcare conglomerate's stock valued at $1,907,000 after acquiring an additional 21 shares during the period. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Down 0.6%

NYSE:UNH opened at $244.42 on Friday. The stock's fifty day moving average price is $292.78 and its two-hundred day moving average price is $408.71. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The company has a market cap of $221.72 billion, a price-to-earnings ratio of 10.59, a P/E/G ratio of 1.59 and a beta of 0.43.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%. The firm had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same period in the prior year, the company posted $6.80 EPS. The firm's quarterly revenue was up 12.9% compared to the same quarter last year. On average, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were given a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 3.6%. The ex-dividend date was Monday, June 16th. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's dividend payout ratio is presently 38.30%.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, CFO John F. Rex bought 17,175 shares of the company's stock in a transaction on Friday, May 16th. The stock was bought at an average price of $291.12 per share, for a total transaction of $4,999,986.00. Following the transaction, the chief financial officer owned 203,796 shares of the company's stock, valued at approximately $59,329,091.52. The trade was a 9.20% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Timothy Patrick Flynn acquired 1,533 shares of the stock in a transaction that occurred on Wednesday, May 14th. The stock was purchased at an average price of $320.80 per share, with a total value of $491,786.40. Following the transaction, the director owned 6,033 shares in the company, valued at $1,935,386.40. This represents a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last ninety days, insiders have purchased 109,408 shares of company stock worth $31,607,768. 0.28% of the stock is owned by company insiders.

Analyst Ratings Changes

UNH has been the topic of several research reports. Wolfe Research decreased their price objective on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating on the stock in a report on Tuesday, May 20th. KeyCorp decreased their price objective on UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating on the stock in a report on Wednesday, July 30th. Truist Financial decreased their price objective on UnitedHealth Group from $360.00 to $345.00 and set a "buy" rating on the stock in a report on Wednesday, July 16th. Wells Fargo & Company decreased their price objective on UnitedHealth Group from $306.00 to $267.00 and set an "overweight" rating on the stock in a report on Monday. Finally, JPMorgan Chase & Co. decreased their price objective on UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating on the stock in a report on Wednesday. Three research analysts have rated the stock with a sell rating, seven have assigned a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of "Hold" and an average price target of $366.52.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.